NR3C1 and COVID-19: GCR expression was decreased in severely ill COVID-19 patients compared to mild patients, prompting the authors to suggest that this may be a reflection of the pathological down-regulation of this endogenous immunomodulatory mechanism, which might be restored with corticosteroid therapy [84].